Preliminary findings from the present study showed that intracellular constitutive levels of glycogen in ESCC cells were significantly lower than in normal TYNEK-3 cells, but were restored following treatment with GSK3β inhibitor. This evidence concerns the gene GSK3B and esophageal squamous cell carcinoma.